Influenza Hemagglutinin (HA) Peptide: Precision in Epitope Tagging for Advanced Protein Research

Principle Overview: HA Tag Peptide as a Versatile Epitope Tag

The Influenza Hemagglutinin (HA) Peptide (sequence: YPYDVPDYA) is a synthetic nine-amino-acid tag derived from the human influenza hemagglutinin protein, widely recognized for its application in molecular biology and biochemistry as an epitope tag for protein detection and purification (source: labpe.com). This HA tag peptide exhibits high purity (>98% by HPLC and MS) and exceptional solubility in water, DMSO, and ethanol, making it a robust tool for competitive binding to Anti-HA antibodies in immunoprecipitation (IP), affinity purification, and protein–protein interaction assays. Its small size minimizes steric hindrance while providing a highly specific target for antibody-based capture and elution workflows (source: cy5-5-nhs-ester.com).

Step-by-Step Workflow: Enhancing Immunoprecipitation and Purification

Deploying the Influenza Hemagglutinin (HA) Peptide in experimental workflows is straightforward yet requires careful optimization. Below is a distilled protocol that leverages its competitive binding properties for efficient elution of HA-tagged fusion proteins in immunoprecipitation with Anti-HA antibody magnetic beads or conventional antibody-conjugated resins.

Protocol Parameters

• Elution buffer supplement | 1 mg/mL HA tag peptide in PBS | Immunoprecipitation elution | Ensures complete displacement of HA-tagged proteins from anti-HA antibody beads, minimizing residual binding and maximizing yield | product_spec
• Incubation temperature | 4°C | Elution step | Maintains protein integrity and reduces protease activity during competitive elution | workflow_recommendation
• Incubation time | 30–60 minutes with gentle agitation | Elution step | Provides sufficient time for competitive binding of HA peptide to antibody, ensuring efficient recovery | workflow_recommendation
• Storage of peptide stock | ≤ –20°C, desiccated | Stock solution management | Maintains peptide stability and prevents hydrolysis or aggregation over time | product_spec
• Solubility limit | 46.2 mg/mL in water | Solution preparation | Enables preparation of highly concentrated stocks for titration and multi-well format assays | product_spec

Advanced Applications and Comparative Advantages

The HA tag peptide stands out in several applied scenarios. Its use as an epitope tag for protein detection allows multiplexing with other tags (e.g., FLAG, Myc) in co-immunoprecipitation or protein interaction studies, facilitating simultaneous interrogation of multiple proteins within complex assemblies (source: labpe.com). Unlike larger fusion tags, the HA tag sequence minimally disrupts protein structure and function, which is critical in studies of posttranslational modifications or spatial localization.

In protein purification workflows, the Influenza Hemagglutinin (HA) Peptide enables highly specific, non-denaturing elution of HA fusion proteins. This is especially valuable in sensitive downstream applications such as enzymatic assays, mass spectrometry, or interaction mapping, as the peptide's competitive binding to Anti-HA antibody avoids harsh chemical or low-pH elution conditions that can denature target proteins (source: r110-azide-5-isomer.com).

Comparative studies have shown that the HA tag peptide delivers superior specificity and recovery compared to conventional tags, particularly in quantitative immunoprecipitation and protein–protein interaction assays (source: z-devd-fmk.com). Its small size also reduces background binding, enhancing signal-to-noise ratios in detection and proteomics workflows.

Key Innovation from the Reference Study

The recent study by Dong et al. (DOI: 10.1002/advs.202504704) leveraged HA-tagged constructs to dissect the molecular mechanisms underlying colorectal cancer metastasis. By deploying a high-throughput shRNA screen and HA epitope tagging, the authors pinpointed NEDD4L as a suppressor of liver metastasis via PRMT5 degradation and AKT/mTOR pathway inhibition. Their workflow depended on robust, specific immunoprecipitation and detection of HA-tagged proteins, highlighting the critical role of the HA tag peptide in ensuring experimental specificity and reproducibility (source: paper).

Practically, this underscores the importance of using a high-purity, reliable HA tag peptide—such as the one from APExBIO—to enable sensitive detection of protein–protein interactions and posttranslational modification states in translational cancer research.

Troubleshooting and Optimization Tips

• Low yield during elution: Increase HA tag peptide concentration incrementally up to 2 mg/mL, or extend incubation time to 90 minutes, to ensure complete competitive displacement of the HA-tagged protein (workflow_recommendation).
• High background or non-specific binding: Ensure thorough washing of beads before elution, and validate antibody specificity with peptide-blocking controls (source: cy5-5-nhs-ester.com).
• Peptide precipitation in stock: Always dissolve the peptide at room temperature, vortex gently, and avoid repeated freeze–thaw cycles. Prepare single-use aliquots at ≤ –20°C as recommended (product_spec).
• Impaired detection in Western blot: Confirm the integrity and orientation of the HA tag in the fusion construct, and use validated anti-HA antibodies for both IP and Western detection (workflow_recommendation).

Interlinking with Related Resources

The article "Influenza Hemagglutinin (HA) Peptide: Precision Epitope Tagging" complements this workflow by offering an in-depth analysis of advanced use-cases and stepwise troubleshooting. For those seeking enhanced quantitative rigor, "Precision in Quantitative Immunoprecipitation Science" extends protocol refinements for next-generation interaction assays. Meanwhile, "Revolutionizing Protein Purification and Exosome Biology" contrasts the HA tag’s performance with alternative tags in exosome workflows, highlighting its superior recovery and specificity in challenging biological samples.

Future Outlook: Toward Multiplexed and Quantitative Interactomics

As demonstrated in the reference study and supporting literature, the Influenza Hemagglutinin (HA) Peptide will continue to underpin advances in molecular oncology and systems biology. Its proven track record in enabling sensitive immunoprecipitation, competitive elution, and quantitative interaction mapping positions it as a cornerstone for multiplexed proteomics and functional genomics (source: paper). The ongoing maturation of antibody and peptide chemistry—combined with high-purity, reliable supply from providers such as APExBIO—will further expand its role in translational research, particularly as studies demand ever-greater specificity, reproducibility, and scalability.